Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever If you're looking for high-yield stocks in the healthcare sector, it's hard to beat this trio of industry giants offering yields of up to 3.9%.
After Merck, Chinese Biotech Hengrui Pharma Collaborates With GSK In Worth $12 Billion Pact GSK and Hengrui Pharma signed a global deal for up to 12 drugs, including COPD therapy, with milestone payments totaling $12 billion.
How To Earn $500 A Month From Merck Stock Ahead Of Q2 Earnings Merck offers a quarterly dividend amount of 81 cents per share. To receive $500 monthly, here's what you do.
3 Surprisingly Underrated Stocks to Buy Right Now These big pharma stocks arguably aren't receiving the respect they deserve.
What To Expect From Merck’s (MRK) Q2 Earnings Global pharmaceutical company Merck (
NYSE:MRK )
will be reporting earnings this Tuesday before market open. Here’s what investors should know.
Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills Sci-fi becomes reality: AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants.
How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma AI-native players like Palantir, Tempus, and Recursion are disrupting drug discovery and attracting investors, while Big Pharma struggles.
Merck & Co. Inc. (NYSE:MRK): A Strong Value Investment with Undervalued Potential Merck & Co. (MRK) is a top value stock with strong fundamentals—undervalued P/E, high profitability, stable finances, and steady growth, making it a smart pick for value investors.
Abivax Hits The Stratosphere, Up 500%, On 'Potentially Disruptive' Results The results represent a best-case scenario for the company in treating inflammatory bowel disease, according to one analyst.
Why Replimune's Surprise Rejection Rattled Wall Street, And Cratered Its Stock The company had lined up a priority review in the hopes of winning an accelerated approval for its melanoma treatment.
MERCK & CO. INC. (NYSE:MRK) – A Quality Stock with Strong Fundamentals MERCK & CO. INC. (
NYSE:MRK ) is a high-quality stock with strong profitability, efficient capital use, and a reliable dividend, making it a solid pick for long-term investors.
1 Dow Jones Stock to Target This Week and 2 to Avoid While the Dow Jones (^DJI) represents industry leaders, not every stock in the index is a safe bet.
Some are facing headwinds like declining demand, rising costs, or disruptive new competitors.
GSK Seeks FDA Nod To Broaden RSV Vaccine For Younger At-Risk Adults FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the first half of 2026.
